Free Trial

This company has been marked as potentially delisted and may not be actively trading.

bluebird bio (BLUE) Earnings Date, Estimates & Call Transcripts

bluebird bio logo

bluebird bio Earnings Summary

bluebird bio posted Q2 2024 earnings on September 27, 2024, reporting an EPS of -$8.40, which missed analysts' consensus estimates of -$8.00 by $0.40. Quarterly revenue was reported to be $16.10 million, above the consensus estimate of $16.09 million. With a trailing EPS of -$41.32, bluebird bio's earnings are expected to grow next year, from ($27.25) to ($11.52) per share.

Q2 2024 Earnings Resources

Latest Q2 2024
Earnings Date
Sep. 27Estimated
Consensus EPS
(Sep. 27)
-$8.00
Actual EPS
(Sep. 27)
-$8.40 Missed By -$0.40
Actual Revenue
(Sep. 27)
$16.10M
Get bluebird bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on bluebird bio and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BLUE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLUE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

bluebird bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20254-$0.38-$0.07-$0.24
Q2 20254-$0.33-$0.05-$0.17
Q3 20254-$0.36$0.01-$0.15
Q4 20254-$0.51-$0.04-$0.23

bluebird bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/27/2024Q2 2024-$8.00-$8.40 -$0.40-$0.42$16.09M$16.10M
9/13/2024Q1 2024--$7.20--$0.36-$18.57M
11/7/2023Q3 2023-$13.80-$13.20+$0.60-$0.66$13.56M$12.40M

bluebird bio Earnings - Frequently Asked Questions

bluebird bio (NASDAQ:BLUE) last announced its quarterly earning data on Friday, September 27, 2024. Learn more on BLUE's earnings history.

In the previous quarter, bluebird bio (NASDAQ:BLUE) missed the analysts' consensus estimate of ($8.00) by $0.40 with a reported earnings per share (EPS) of ($8.40). Learn more on analysts' earnings estimate vs. BLUE's actual earnings.

bluebird bio (NASDAQ:BLUE) has a recorded annual revenue of $103.95 million.

bluebird bio (NASDAQ:BLUE) has a recorded net income of -$211.91 million. BLUE has generated -$41.32 earnings per share over the last four quarters.

bluebird bio's earnings are expected to grow from ($27.25) per share to ($11.52) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BLUE) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners